Published in Ann Allergy Asthma Immunol on November 01, 2012
The Bet v 1 fold: an ancient, versatile scaffold for binding of large, hydrophobic ligands. BMC Evol Biol (2008) 2.15
Eosinophilic gastrointestinal disease suggestive of pathogenesis-related class 10 (PR-10) protein allergy resolved after immunotherapy. J Allergy Clin Immunol (2013) 2.06
Crystal structure of a hypoallergenic isoform of the major birch pollen allergen Bet v 1 and its likely biological function as a plant steroid carrier. J Mol Biol (2003) 1.99
Allergens are distributed into few protein families and possess a restricted number of biochemical functions. J Allergy Clin Immunol (2008) 1.77
Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J (2002) 1.66
A classification of plant food allergens. J Allergy Clin Immunol (2004) 1.48
Nomenclature and structural biology of allergens. J Allergy Clin Immunol (2006) 1.45
Novel allergens from ancient foods: Man e 5 from manioc (Manihot esculenta Crantz) cross reacts with Hev b 5 from latex. Mol Nutr Food Res (2013) 1.41
Apple allergy across Europe: how allergen sensitization profiles determine the clinical expression of allergies to plant foods. J Allergy Clin Immunol (2006) 1.30
Evolutionary biology of plant food allergens. J Allergy Clin Immunol (2007) 1.16
Evolutionary distance from human homologs reflects allergenicity of animal food proteins. J Allergy Clin Immunol (2007) 1.11
Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine (2003) 1.10
Plant-based heterologous expression of Mal d 2, a thaumatin-like protein and allergen of apple (Malus domestica), and its characterization as an antifungal protein. J Mol Biol (2003) 1.09
Pollen allergens are restricted to few protein families and show distinct patterns of species distribution. J Allergy Clin Immunol (2005) 1.09
IgE cross-reactivity between the major peanut allergen Ara h 2 and the nonhomologous allergens Ara h 1 and Ara h 3. J Allergy Clin Immunol (2013) 1.07
Crystal structure of the major celery allergen Api g 1: molecular analysis of cross-reactivity. J Mol Biol (2005) 1.06
Structural and immunologic characterization of Ara h 1, a major peanut allergen. J Biol Chem (2011) 1.03
Mutational analysis of amino acid positions crucial for IgE-binding epitopes of the major apple (Malus domestica) allergen, Mal d 1. Int Arch Allergy Immunol (2005) 1.02
Thaumatin-like proteins -- a new family of pollen and fruit allergens. Allergy (2004) 1.02
Naturally occurring hypoallergenic Bet v 1 isoforms fail to induce IgE responses in individuals with birch pollen allergy. J Allergy Clin Immunol (2007) 1.01
The European Union CREATE project: a model for international standardization of allergy diagnostics and vaccines. J Allergy Clin Immunol (2008) 1.01
Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis. J Allergy Clin Immunol (2008) 1.00
Peanut-specific IgE antibodies in asymptomatic Ghanaian children possibly caused by carbohydrate determinant cross-reactivity. J Allergy Clin Immunol (2013) 0.99
The constitutive expression of galectin-3 is downregulated in the intestinal epithelia of Crohn's disease patients, and tumour necrosis factor alpha decreases the level of galectin-3-specific mRNA in HCT-8 cells. Eur J Gastroenterol Hepatol (2002) 0.99
Structural relatedness of plant food allergens with specific reference to cross-reactive allergens: an in silico analysis. J Allergy Clin Immunol (2005) 0.97
Sequence variability of the pattern recognition receptor Mermaid mediates specificity of marine nematode symbioses. ISME J (2011) 0.94
Component-resolved diagnosis of kiwifruit allergy with purified natural and recombinant kiwifruit allergens. J Allergy Clin Immunol (2010) 0.91
Entamoeba histolytica: analysis of the trophozoite proteome by two-dimensional polyacrylamide gel electrophoresis. Exp Parasitol (2005) 0.91
A new allergen from ragweed (Ambrosia artemisiifolia) with homology to art v 1 from mugwort. J Biol Chem (2010) 0.89
Allergic sensitization: food- and protein-related factors. Clin Transl Allergy (2014) 0.89
Purification and characterisation of a panel of peanut allergens suitable for use in allergy diagnosis. Mol Nutr Food Res (2008) 0.89
Latex allergy within a cohort of not-at-risk subjects with respiratory symptoms: prevalence of latex sensitization and assessment of diagnostic tools. Int Arch Allergy Immunol (2007) 0.88
Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu. Int J Cancer (2003) 0.88
Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001. Immunobiology (2009) 0.87
Purification and structural stability of the peach allergens Pru p 1 and Pru p 3. Mol Nutr Food Res (2008) 0.87
Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro. J Immunol (2005) 0.86
Kiwifruit allergy across Europe: clinical manifestation and IgE recognition patterns to kiwifruit allergens. J Allergy Clin Immunol (2012) 0.86
Cross-reactivity of peanut allergens. Curr Allergy Asthma Rep (2014) 0.86
Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody. Int J Cancer (2005) 0.85
Crystallization and preliminary structure determination of the plant food allergen Pru av 2. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.85
Differences among pollen-allergic patients with and without plant food allergy. Int Arch Allergy Immunol (2010) 0.84
How accurate and safe is the diagnosis of hazelnut allergy by means of commercial skin prick test reagents? Int Arch Allergy Immunol (2003) 0.84
Specificity of mimotope-induced anti-high molecular weight-melanoma associated antigen (HMW-MAA) antibodies does not ensure biological activity. PLoS One (2011) 0.84
Single-chain antibodies to the EWS NH(2) terminus structurally discriminate between intact and chimeric EWS in Ewing's sarcoma and interfere with the transcriptional activity of EWS in vivo. Cancer Res (2006) 0.84
Hevea brasiliensis latex allergens: current panel and clinical relevance. Int Arch Allergy Immunol (2005) 0.84
Component-resolved IgE profiles in Austrian patients with a convincing history of peanut allergy. Int Arch Allergy Immunol (2015) 0.83
A novel concept for detoxification: complexation between aconitine and liquiritin in a Chinese herbal formula ('Sini Tang'). J Ethnopharmacol (2013) 0.83
Latex-allergic patients sensitized to the major allergen hevein and hevein-like domains of class I chitinases show no increased frequency of latex-associated plant food allergy. Mol Immunol (2010) 0.83
Role of the polypeptide backbone and post-translational modifications in cross-reactivity of Art v 1, the major mugwort pollen allergen. Biol Chem (2009) 0.82
Effects of gastrointestinal digestion and heating on the allergenicity of the kiwi allergens Act d 1, actinidin, and Act d 2, a thaumatin-like protein. Mol Nutr Food Res (2008) 0.82
Reduction of human melanoma tumor growth in severe combined immunodeficient mice by passive transfer of antibodies induced by a high molecular weight melanoma-associated antigen mimotope vaccine. Clin Cancer Res (2008) 0.82
Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice. Breast Cancer Res Treat (2007) 0.82
The alpha and beta subchain of Amb a 1, the major ragweed-pollen allergen show divergent reactivity at the IgE and T-cell level. Mol Immunol (2009) 0.82
Specific IgE response to purified and recombinant allergens in latex allergy. Clin Mol Allergy (2005) 0.81
Plant virus expression systems for transient production of recombinant allergens in Nicotiana benthamiana. Methods (2004) 0.81
Lab scale and medium scale production of recombinant allergens in Escherichia coli. Methods (2004) 0.81
Patterns of reactivity to lipid transfer proteins of plant foods and Artemisia pollen: an in vivo study. Int Arch Allergy Immunol (2002) 0.81
Purification and characterisation of relevant natural and recombinant apple allergens. Mol Nutr Food Res (2008) 0.81
Genetic engineering of allergens: future therapeutic products. Int Arch Allergy Immunol (2002) 0.80
The purification and characterisation of allergenic hazelnut seed proteins. Mol Nutr Food Res (2008) 0.80
The panel of egg allergens, Gal d 1-Gal d 5: Their improved purification and characterization. Mol Nutr Food Res (2008) 0.80
Oil body-associated hazelnut allergens including oleosins are underrepresented in diagnostic extracts but associated with severe symptoms. Clin Transl Allergy (2014) 0.80
Expression of the B subunit of the heat-labile enterotoxin of Escherichia coli in tobacco mosaic virus-infected Nicotiana benthamiana plants and its characterization as mucosal immunogen and adjuvant. J Immunol Methods (2004) 0.79
Solution and high-pressure NMR studies of the structure, dynamics, and stability of the cross-reactive allergenic cod parvalbumin Gad m 1. Proteins (2014) 0.79
Production and characterization of an allergen panel for component-resolved diagnosis of celery allergy. Mol Nutr Food Res (2008) 0.79
Allergy multivaccines created by DNA shuffling of tree pollen allergens. J Allergy Clin Immunol (2007) 0.79
Effects of established allergen sensitization on immune and airway responses after secondary allergen sensitization. J Allergy Clin Immunol (2006) 0.78
Mal d 2, the thaumatin-like allergen from apple, is highly resistant to gastrointestinal digestion and thermal processing. Int Arch Allergy Immunol (2008) 0.78
A non-allergenic Ole e 1-like protein from birch pollen as a tool to design hypoallergenic vaccine candidates. Mol Immunol (2012) 0.78
Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses. Vaccine (2007) 0.78
Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy. Int Arch Allergy Immunol (2015) 0.78
Cross-reactivity of mimotopes with a monoclonal antibody against the high molecular weight melanoma-associated antigen (HMW-MAA) does not predict cross-reactive immunogenicity. Melanoma Res (2005) 0.78
Exercise with latex sport bands represents a risk for latex allergic patients. Immunol Lett (2007) 0.78
Structural and bioinformatic analysis of the kiwifruit allergen Act d 11, a member of the family of ripening-related proteins. Mol Immunol (2013) 0.77
NADP-dependent mannitol dehydrogenase, a major allergen of Cladosporium herbarum. J Biol Chem (2006) 0.77
Immediate hypersensitivity to levofloxacin diagnosed through skin prick test. Ann Pharmacother (2003) 0.77
Outcome and safety of double-blind, placebo-controlled food challenges in 111 patients sensitized to lipid transfer proteins. J Allergy Clin Immunol (2008) 0.77
IgE sensitization profiles toward green and gold kiwifruits differ among patients allergic to kiwifruit from 3 European countries. J Allergy Clin Immunol (2004) 0.77
Identification of a 7S globulin as a novel coconut allergen. Ann Allergy Asthma Immunol (2007) 0.77
Vig r 6, the cytokinin-specific binding protein from mung bean (Vigna radiata) sprouts, cross-reacts with Bet v 1-related allergens and binds IgE from birch pollen allergic patients' sera. Mol Nutr Food Res (2013) 0.77
A label-free indicator for tumor cells based on the CH2-stretch ratio. Analyst (2011) 0.77
Pru p 3 as a marker for symptom severity for patients with peach allergy in a birch pollen environment. J Allergy Clin Immunol (2009) 0.77